ArticleArXiv2025
Resolving structural dynamics in situ through cryogenic electron tomography.
Article in ArXiv, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
2 authors.
Funding
Abstract
Cryo-electron tomography (cryo-ET) has emerged as a powerful tool for studying the structural heterogeneity of proteins and their complexes, offering insights into macromolecular dynamics directly within cells. Driven by recent computational advances, including powerful machine learning frameworks, researchers can now resolve both discrete structural states and continuous conformational changes from 3D subtomograms and stacks of 2D particle-images acquired across tilt-series. In this review, we survey recent innovations in particle classification and heterogeneous 3D reconstruction methods, focusing specifically on the relative merits of workflows that operate on reconstructed 3D subtomogram volumes compared to those using extracted 2D particle-images. We additionally highlight how these methods have provided specific biological insights into the organization, dynamics, and structural variability of cellular components. Finally, we advocate for the development of benchmarking datasets collected in vitro and in situ to enable a more objective comparison of existent and emerging methods for particle classification and heterogeneous 3D reconstruction.
Identifiers
41019205PMC12461809What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.